Insider Transactions Reported by 9 Insiders of RELMADA THERAPEUTICS, INC.

Symbol
RLMD on Nasdaq
Location
Coral Gables, FL

Insiders trading volume in the past year

RELMADA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sergio Traversa Chief Executive Officer, Director $5,356,000 +$1,065,608 +25% 12 Dec 2025
Maged Shenouda Chief Financial Officer $3,296,000 +$1,245,268 +61% 12 Dec 2025
Paul Edward Kelly COO, Director $1,105,049 +$284,060 +35% 12 Dec 2025
Chuck Ence CA and CO $888,648 +$402,530 +83% 12 Dec 2025
Cedric O'Gorman Chief Medical Officer $32,185 23 May 2023
Fabiana Fedeli Director 12 Dec 2025
Charles J. Casamento Director 12 Dec 2025
John Glasspool Director 12 Dec 2025
Eric Thomas Schmidt Director 25 May 2023

Recent Insider Transactions by Companies or Individuals for RELMADA THERAPEUTICS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Sergio Traversa RLMD Common Stock Purchase 2.16% $113,300 $4.12 27,500 1,300,000 15 Dec 2025 Direct
Maged Shenouda RLMD Common Stock Purchase 1.48% $48,060 $4.12 11,665 800,000 15 Dec 2025 Direct
Sergio Traversa RLMD Stock Appreciation Rights Award 1,198,000 1,198,000 12 Dec 2025 Direct
Maged Shenouda RLMD Stock Appreciation Rights Award 828,000 828,000 12 Dec 2025 Direct
Chuck Ence RLMD Stock Appreciation Rights Award 828,000 828,000 12 Dec 2025 Direct
Fabiana Fedeli RLMD Stock Appreciation Rights Award 164,000 164,000 12 Dec 2025 Direct
John Glasspool RLMD Stock Appreciation Rights Award 164,000 164,000 12 Dec 2025 Direct
Paul Edward Kelly RLMD Stock Appreciation Rights Award 828,000 828,000 12 Dec 2025 Direct
Charles J. Casamento RLMD Stock Appreciation Rights Award 164,000 164,000 12 Dec 2025 Direct
Chuck Ence RLMD Common Stock Purchase 50.8% $299,200 $2.20 136,000 403,931 05 Nov 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 27.2% $599,500 $2.20 272,500 1,272,500 05 Nov 2025 Direct
Maged Shenouda RLMD Common Stock Purchase 173.4% $1,100,000 $2.20 500,000 788,335 05 Nov 2025 Direct
Paul Edward Kelly RLMD Common Stock Purchase 21.8% $198,000 $2.20 90,000 502,295 05 Nov 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 5.93% $41,422 $0.7400 55,976 1,000,000 28 Aug 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 15.9% $86,735 $0.6700 129,455 944,024 27 Aug 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 11% $49,938 $0.6200 80,545 814,569 26 Aug 2025 Direct
Chuck Ence RLMD Stock Option (right to buy) Award 400,000 400,000 26 Jun 2025 Direct
Maged Shenouda RLMD Stock Option (right to buy) Award 600,000 600,000 26 Jun 2025 Direct
Sergio Traversa RLMD Stock Option (right to buy) Award 800,000 800,000 26 Jun 2025 Direct
Charles J. Casamento RLMD Stock Option (right to buy) Award 100,000 100,000 26 Jun 2025 Direct
John Glasspool RLMD Stock Option (right to buy) Award 100,000 100,000 26 Jun 2025 Direct
Fabiana Fedeli RLMD Stock Option (right to buy) Award 100,000 100,000 26 Jun 2025 Direct
Paul Edward Kelly RLMD Stock Option (right to buy) Award 400,000 400,000 26 Jun 2025 Direct
Maged Shenouda RLMD Common Stock Purchase 26.3% $31,422 $0.5237 60,000 288,335 20 May 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 25.2% $82,246 $0.5569 147,686 734,024 20 May 2025 Direct
Maged Shenouda RLMD Common Stock Purchase 65.1% $43,686 $0.4854 90,000 228,335 19 May 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 5.39% $14,994 $0.4998 30,000 586,338 19 May 2025 Direct
Paul Edward Kelly RLMD Common Stock Purchase 94.2% $86,060 $0.4303 200,000 412,295 16 May 2025 Direct
Maged Shenouda RLMD Common Stock Purchase 56.6% $22,100 $0.4420 50,000 138,335 16 May 2025 Direct
Chuck Ence RLMD Common Stock Purchase 587.5% $103,330 $0.4513 228,961 267,931 16 May 2025 Direct
Sergio Traversa RLMD Common Stock Purchase 44.9% $77,472 $0.4496 172,314 556,338 16 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.